| Year |
Citation |
Score |
| 2023 |
Levinstein MR, De Oliveira PA, Casajuana-Martin N, Quiroz C, Budinich RC, Rais R, Rea W, Ventriglia EN, Llopart N, Casadó-Anguera V, Moreno E, Walther D, Glatfelter GC, Weinshenker D, Zarate CA, et al. Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone. Molecular Psychiatry. PMID 38145984 DOI: 10.1038/s41380-023-02353-z |
0.346 |
|
| 2023 |
Homar-Ruano P, Cai NS, Casadó-Anguera V, Casadó V, Ferré S, Moreno E, Canela EI. Significant Functional Differences Between Dopamine D Receptor Polymorphic Variants Upon Heteromerization with α Adrenoreceptors. Molecular Neurobiology. PMID 37464153 DOI: 10.1007/s12035-023-03476-8 |
0.431 |
|
| 2023 |
Ferré S, Köfalvi A, Ciruela F, Justinova Z, Pistis M. Targeting corticostriatal transmission for the treatment of cannabinoid use disorder. Trends in Pharmacological Sciences. PMID 37331914 DOI: 10.1016/j.tips.2023.05.003 |
0.464 |
|
| 2023 |
Ferré S, Pardo L, Ciruela F. Clues from a missense mutation of the adenosine A receptor gene associated with early-onset Parkinson's disease. Neural Regeneration Research. 18: 2204-2205. PMID 37056138 DOI: 10.4103/1673-5374.369113 |
0.304 |
|
| 2023 |
Valle-León M, Casajuana-Martin N, Del Torrent CL, Argerich J, Gómez-Acero L, Sahlholm K, Ferré S, Pardo L, Ciruela F. Unique effect of clozapine on adenosine A-dopamine D receptor heteromerization. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 160: 114327. PMID 36736280 DOI: 10.1016/j.biopha.2023.114327 |
0.412 |
|
| 2022 |
Ferré S, Sarasola LI, Quiroz C, Ciruela F. Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum. Neuropharmacology. 223: 109329. PMID 36375695 DOI: 10.1016/j.neuropharm.2022.109329 |
0.546 |
|
| 2022 |
Sarasola LI, Del Torrent CL, Pérez-Arévalo A, Argerich J, Casajuana-Martín N, Chevigné A, Fernández-Dueñas V, Ferré S, Pardo L, Ciruela F. The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A-A receptor heteromer formation and function. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 156: 113896. PMID 36279718 DOI: 10.1016/j.biopha.2022.113896 |
0.336 |
|
| 2022 |
Ferré S, Belcher AM, Bonaventura J, Quiroz C, Sánchez-Soto M, Casadó-Anguera V, Cai NS, Moreno E, Boateng CA, Keck TM, Florán B, Earley CJ, Ciruela F, Casadó V, Rubinstein M, et al. Functional and pharmacological role of the dopamine D receptor and its polymorphic variants. Frontiers in Endocrinology. 13: 1014678. PMID 36267569 DOI: 10.3389/fendo.2022.1014678 |
0.501 |
|
| 2022 |
Moreno E, Casajuana-Martin N, Coyle M, Campos BC, Galaj E, Del Torrent CL, Seyedian A, Rea W, Cai NS, Bonifazi A, Florán B, Xi ZX, Guitart X, Casadó V, Newman AH, et al. Pharmacological targeting of G protein-coupled receptor heteromers. Pharmacological Research. 106476. PMID 36182040 DOI: 10.1016/j.phrs.2022.106476 |
0.469 |
|
| 2022 |
De Oliveira PA, Moreno E, Casajuana-Martin N, Casadó-Anguera V, Cai NS, Camacho-Hernandez GA, Zhu H, Bonifazi A, Hall MD, Weinshenker D, Newman AH, Logothetis DE, Casadó V, Plant LD, Pardo L, et al. Preferential Gs protein coupling of the galanin Gal receptor in the µ-opioid-Gal receptor heterotetramer. Pharmacological Research. 182: 106322. PMID 35750299 DOI: 10.1016/j.phrs.2022.106322 |
0.434 |
|
| 2022 |
Rodrigues MS, Ferreira SG, Quiroz C, Earley CJ, García-Borreguero D, Cunha RA, Ciruela F, Köfalvi A, Ferré S. Brain Iron Deficiency Changes the Stoichiometry of Adenosine Receptor Subtypes in Cortico-Striatal Terminals: Implications for Restless Legs Syndrome. Molecules (Basel, Switzerland). 27. PMID 35268590 DOI: 10.3390/molecules27051489 |
0.581 |
|
| 2022 |
Pulido D, Casadó-Anguera V, Gómez-Autet M, Llopart N, Moreno E, Casajuana-Martin N, Ferré S, Pardo L, Casadó V, Royo M. Heterobivalent Ligand for the Adenosine A-Dopamine D Receptor Heteromer. Journal of Medicinal Chemistry. 65: 616-632. PMID 34982555 DOI: 10.1021/acs.jmedchem.1c01763 |
0.435 |
|
| 2021 |
Navarro G, Rea W, Quiroz C, Moreno E, Gomez D, Wenthur CJ, Casadó V, Leggio L, Hearing MC, Ferré S. Complexes of ghrelin GHS-R1a, GHS-R1b and dopamine D receptors localized in the ventral tegmental area as main mediators of the dopaminergic effects of ghrelin. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34876469 DOI: 10.1523/JNEUROSCI.1151-21.2021 |
0.418 |
|
| 2021 |
Fernández-Dueñas V, Bonaventura J, Aso E, Luján R, Ferré S, Ciruela F. Overcoming the challenges of detecting gpcr oligomerization in the brain. Current Neuropharmacology. PMID 34736381 DOI: 10.2174/1570159X19666211104145727 |
0.536 |
|
| 2021 |
Ferré S, Ciruela F, Dessauer CW, González-Maeso J, Hébert TE, Jockers R, Logothetis DE, Pardo L. G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs). Pharmacology & Therapeutics. 107977. PMID 34480967 DOI: 10.1016/j.pharmthera.2021.107977 |
0.359 |
|
| 2021 |
Casadó-Anguera V, Moreno E, Sánchez-Soto M, Cai NS, Bonaventura J, Homar-Ruano P, Rubinstein M, Cortés A, Canela EI, Ferré S, Casadó V. Heteromerization between α adrenoceptors and different polymorphic variants of the dopamine D receptor determines pharmacological and functional differences. Implications for impulsive-control disorders. Pharmacological Research. 105745. PMID 34182128 DOI: 10.1016/j.phrs.2021.105745 |
0.432 |
|
| 2021 |
Ferré S, Guitart X, Quiroz C, Rea W, García-Malo C, Garcia-Borreguero D, Allen RP, Earley CJ. Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox. Sleep Medicine Clinics. 16: 249-267. PMID 33985651 DOI: 10.1016/j.jsmc.2021.02.012 |
0.598 |
|
| 2020 |
Valle-León M, Callado LF, Aso E, Cajiao-Manrique MM, Sahlholm K, López-Cano M, Soler C, Altafaj X, Watanabe M, Ferré S, Fernández-Dueñas V, Menchón JM, Ciruela F. Decreased striatal adenosine A-dopamine D receptor heteromerization in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33010795 DOI: 10.1038/s41386-020-00872-9 |
0.375 |
|
| 2020 |
Adrover MF, Shin JH, Quiroz C, Ferré S, Lemos JC, Alvarez VA. Prefrontal cortex driven dopamine signals in the striatum show unique spatial and pharmacological properties. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32859717 DOI: 10.1523/JNEUROSCI.1327-20.2020 |
0.353 |
|
| 2020 |
Moreno-Delgado D, Puigdellívol M, Moreno E, Rodríguez-Ruiz M, Botta J, Gasperini P, Chiarlone A, Howell LA, Scarselli M, Casadó V, Cortés A, Ferré S, Guzmán M, Lluís C, Alberch J, et al. Modulation of dopamine D receptors via histamine H receptors is a novel therapeutic target for Huntington's disease. Elife. 9. PMID 32513388 DOI: 10.7554/Elife.51093 |
0.478 |
|
| 2020 |
Köfalvi A, Moreno E, Cordomí A, Cai NS, Fernández-Dueñas V, Ferreira SG, Guixà-González R, Sánchez-Soto M, Yano H, Casadó-Anguera V, Cunha RA, Sebastião AM, Ciruela F, Pardo L, Casadó V, et al. Control of glutamate release by complexes of adenosine and cannabinoid receptors. Bmc Biology. 18: 9. PMID 31973708 DOI: 10.1186/S12915-020-0739-0 |
0.621 |
|
| 2020 |
Ferré S, Ciruela F, Casadó V, Pardo L. Oligomerization of G protein-coupled receptors: Still doubted? Progress in Molecular Biology and Translational Science. 169: 297-321. PMID 31952690 DOI: 10.1016/Bs.Pmbts.2019.11.006 |
0.328 |
|
| 2019 |
Ferré S, Ciruela F. Functional and Neuroprotective Role of Striatal Adenosine A Receptor Heterotetramers. Journal of Caffeine and Adenosine Research. 9: 89-97. PMID 31559390 DOI: 10.1089/caff.2019.0008 |
0.54 |
|
| 2019 |
Ferré S, Quiroz C, Rea W, Guitart X, García-Borreguero D. Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transport. Advances in Pharmacology (San Diego, Calif.). 84: 3-19. PMID 31229176 DOI: 10.1016/bs.apha.2018.12.005 |
0.358 |
|
| 2019 |
Guitart X, Moreno E, Rea W, Sánchez-Soto M, Cai NS, Quiroz C, Kumar V, Bourque L, Cortés A, Canela EI, Bishop C, Newman AH, Casadó V, Ferré S. Biased G Protein-Independent Signaling of Dopamine D-D Receptor Heteromers in the Nucleus Accumbens. Molecular Neurobiology. PMID 30919214 DOI: 10.1007/S12035-019-1564-8 |
0.431 |
|
| 2018 |
Ferré S, Díaz-Ríos M, Salamone JD, Prediger RD. New Developments on the Adenosine Mechanisms of the Central Effects of Caffeine and Their Implications for Neuropsychiatric Disorders. Journal of Caffeine and Adenosine Research. 8: 121-131. PMID 30596206 DOI: 10.1089/caff.2018.0017 |
0.621 |
|
| 2018 |
Casadó-Anguera V, Moreno E, Mallol J, Ferré S, Canela EI, Cortés A, Casadó V. Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model. Pharmacological Research. 139: 337-347. PMID 30472462 DOI: 10.1016/j.phrs.2018.11.032 |
0.361 |
|
| 2018 |
Sánchez-Soto M, Yano H, Cai NS, Casadó-Anguera V, Moreno E, Casadó V, Ferré S. Revisiting the Functional Role of Dopamine D Receptor Gene Polymorphisms: Heteromerization-Dependent Gain of Function of the D Receptor Variant. Molecular Neurobiology. PMID 30387076 DOI: 10.1007/S12035-018-1413-1 |
0.411 |
|
| 2018 |
Secci ME, Mascia P, Sagheddu C, Beggiato S, Melis M, Borelli AC, Tomasini MC, Panlilio LV, Schindler CW, Tanda G, Ferré S, Bradberry CW, Ferraro L, Pistis M, Goldberg SR, et al. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas. Molecular Neurobiology. PMID 30151725 DOI: 10.1007/s12035-018-1319-y |
0.345 |
|
| 2018 |
Blum D, Chern Y, Domenici MR, Buée L, Lin CY, Rea W, Ferré S, Popoli P. The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease. Journal of Caffeine and Adenosine Research. 8: 43-58. PMID 30023989 DOI: 10.1089/caff.2018.0006 |
0.439 |
|
| 2018 |
Lanza K, Meadows SM, Chambers NE, Nuss E, Deak MM, Ferré S, Bishop C. Behavioral and cellular dopamine D and D receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia. Neuropharmacology. PMID 29936243 DOI: 10.1016/J.Neuropharm.2018.06.024 |
0.408 |
|
| 2018 |
Rivera-Oliver M, Moreno E, Álvarez-Bagnarol Y, Ayala-Santiago C, Cruz-Reyes N, Molina-Castro GC, Clemens S, Canela EI, Ferré S, Casadó V, Díaz-Ríos M. Adenosine A-Dopamine D Receptor Heteromers Control the Excitability of the Spinal Motoneuron. Molecular Neurobiology. PMID 29797183 DOI: 10.1007/S12035-018-1120-Y |
0.392 |
|
| 2018 |
Ferré S, Bonaventura J, Zhu W, Hatcher-Solis C, Taura J, Quiroz C, Cai NS, Moreno E, Casadó-Anguera V, Kravitz AV, Thompson KR, Tomasi DG, Navarro G, Cordomí A, Pardo L, et al. Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A-Dopamine D Receptor Heterotetramers and Adenylyl Cyclase. Frontiers in Pharmacology. 9: 243. PMID 29686613 DOI: 10.3389/Fphar.2018.00243 |
0.615 |
|
| 2018 |
Navarro G, Cordomí A, Casadó-Anguera V, Moreno E, Cai NS, Cortés A, Canela EI, Dessauer CW, Casadó V, Pardo L, Lluís C, Ferré S. Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase. Nature Communications. 9: 1242. PMID 29593213 DOI: 10.1038/S41467-018-03522-3 |
0.332 |
|
| 2018 |
Fernandez-Duenas V, Ferré S, Ciruela F. Adenosine A-dopamine Dreceptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics. Neural Regeneration Research. 13: 241-243. PMID 29557372 DOI: 10.4103/1673-5374.226388 |
0.302 |
|
| 2018 |
Sánchez-Soto M, Casadó-Anguera V, Yano H, Bender BJ, Cai NS, Moreno E, Canela EI, Cortés A, Meiler J, Casadó V, Ferré S. α- and α-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands. Molecular Neurobiology. PMID 29552726 DOI: 10.1007/S12035-018-1004-1 |
0.488 |
|
| 2018 |
Navarro G, Cordomí A, Brugarolas M, Moreno E, Aguinaga D, Pérez-Benito L, Ferre S, Cortés A, Casadó V, Mallol J, Canela EI, Lluís C, Pardo L, McCormick PJ, Franco R. Cross-communication between Gand Gin a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain. Bmc Biology. 16: 24. PMID 29486745 DOI: 10.1186/S12915-018-0491-X |
0.454 |
|
| 2018 |
Yano H, Cai NS, Xu M, Verma RK, Rea W, Hoffman AF, Shi L, Javitch JA, Bonci A, Ferré S. Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor. Nature Communications. 9: 486. PMID 29402888 DOI: 10.1038/S41467-017-02606-W |
0.569 |
|
| 2017 |
Ferré S, Quiroz C, Guitart X, Rea W, Seyedian A, Moreno E, Casadó-Anguera V, Díaz-Ríos M, Casadó V, Clemens S, Allen RP, Earley CJ, García-Borreguero D. Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome. Frontiers in Neuroscience. 11: 722. PMID 29358902 DOI: 10.3389/Fnins.2017.00722 |
0.462 |
|
| 2017 |
Fernández-Dueñas V, Pérez-Arévalo A, Altafaj X, Ferré S, Ciruela F. Adenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease. Frontiers in Neuroscience. 11: 652. PMID 29213228 DOI: 10.3389/Fnins.2017.00652 |
0.379 |
|
| 2017 |
Yano H, Provasi D, Cai NS, Filizola M, Ferre S, Javitch JA. Development of novel biosensors to study receptor-mediated activation of Gs and Golf. The Journal of Biological Chemistry. PMID 29042444 DOI: 10.1074/Jbc.M117.800698 |
0.595 |
|
| 2017 |
Ferré S. Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use Disorders. Current Treatment Options in Psychiatry. 4: 167-183. PMID 28580231 DOI: 10.1007/s40501-017-0109-x |
0.43 |
|
| 2017 |
Bonaventura J, Quiroz C, Cai NS, Rubinstein M, Tanda G, Ferré S. Key role of the dopamine D4 receptor in the modulation of corticostriatal glutamatergic neurotransmission. Science Advances. 3: e1601631. PMID 28097219 DOI: 10.1126/Sciadv.1601631 |
0.521 |
|
| 2016 |
Moreno E, Quiroz C, Rea W, Cai NS, Mallol J, Cortés A, Lluís C, Canela EI, Casadó V, Ferré S. Functional μ-opioid-galanin receptor heteromers in the ventral tegmental area. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28007761 DOI: 10.1523/JNEUROSCI.2442-16.2016 |
0.393 |
|
| 2016 |
Guitart X, Bonaventura J, Rea W, Orrú M, Cellai L, Dettori I, Pedata F, Brugarolas M, Cortés A, Casadó V, Chang CP, Narayanan M, Chern Y, Ferré S. Equilibrative Nucleoside Transporter ENT1 as a Biomarker of Huntington Disease. Neurobiology of Disease. PMID 27567601 DOI: 10.1016/J.Nbd.2016.08.013 |
0.526 |
|
| 2016 |
Earley CJ, Uhl GR, Clemens S, Ferré S. Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation. Sleep Medicine. PMID 27539027 DOI: 10.1016/J.Sleep.2016.06.003 |
0.623 |
|
| 2016 |
Casadó-Anguera V, Bonaventura J, Moreno E, Navarro G, Cortés A, Ferré S, Casadó V. Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex. Biochemical Society Transactions. 44: 595-600. PMID 27068975 DOI: 10.1042/BST20150276 |
0.602 |
|
| 2016 |
Mammoli V, Bonifazi A, Dal Ben D, Giannella M, Giorgioni G, Piergentili A, Pigini M, Quaglia W, Thomas A, Newman AH, Ferré S, Sanchez-Soto M, Keck TM, Del Bello F. A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus. Chemmedchem. PMID 26990230 DOI: 10.1002/Cmdc.201600022 |
0.478 |
|
| 2016 |
Sanchez-Soto M, Bonifazi A, Cai NS, Ellenberger MP, Newman AH, Ferre S, Yano H. Evidence for Non-Canonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-like Receptor Agonist. Molecular Pharmacology. PMID 26843180 DOI: 10.1124/Mol.115.101808 |
0.638 |
|
| 2016 |
Ferré S, Sebastião AM. Dissecting striatal adenosine-cannabinoid receptor interactions. New clues from rats over-expressing adenosine A2A receptors. Journal of Neurochemistry. 136: 897-899. PMID 26806455 DOI: 10.1111/Jnc.13520 |
0.512 |
|
| 2016 |
Quiroz C, Orrú M, Rea W, Ciudad-Roberts A, Yepes G, Britt JP, Ferré S. Local Control of Extracellular Dopamine Levels in the Medial Nucleus Accumbens by a Glutamatergic Projection from the Infralimbic Cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 851-9. PMID 26791215 DOI: 10.1523/Jneurosci.2850-15.2016 |
0.346 |
|
| 2015 |
Bonaventura J, Navarro G, Casadó-Anguera V, Azdad K, Rea W, Moreno E, Brugarolas M, Mallol J, Canela EI, Lluís C, Cortés A, Volkow ND, Schiffmann SN, Ferré S, Casadó V. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer. Proceedings of the National Academy of Sciences of the United States of America. 112: E3609-18. PMID 26100888 DOI: 10.1073/pnas.1507704112 |
0.658 |
|
| 2015 |
Ferré S, Bonaventura J, Tomasi D, Navarro G, Moreno E, Cortés A, Lluís C, Casadó V, Volkow ND. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer. Neuropharmacology. PMID 26051403 DOI: 10.1016/j.neuropharm.2015.05.028 |
0.595 |
|
| 2015 |
Ferré S. The GPCR heterotetramer: challenging classical pharmacology. Trends in Pharmacological Sciences. 36: 145-52. PMID 25704194 DOI: 10.1016/j.tips.2015.01.002 |
0.357 |
|
| 2014 |
Navarro G, Aguinaga D, Moreno E, Hradsky J, Reddy PP, Cortés A, Mallol J, Casadó V, Mikhaylova M, Kreutz MR, Lluís C, Canela EI, McCormick PJ, Ferré S. Intracellular calcium levels determine differential modulation of allosteric interactions within G protein-coupled receptor heteromers. Chemistry & Biology. 21: 1546-56. PMID 25457181 DOI: 10.1016/J.Chembiol.2014.10.004 |
0.393 |
|
| 2014 |
Guitart X, Navarro G, Moreno E, Yano H, Cai NS, Sánchez-Soto M, Kumar-Barodia S, Naidu YT, Mallol J, Cortés A, Lluís C, Canela EI, Casadó V, McCormick PJ, Ferré S. Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer. Molecular Pharmacology. 86: 417-29. PMID 25097189 DOI: 10.1124/Mol.114.093096 |
0.585 |
|
| 2014 |
Moreno E, Moreno-Delgado D, Navarro G, Hoffmann HM, Fuentes S, Rosell-Vilar S, Gasperini P, Rodríguez-Ruiz M, Medrano M, Mallol J, Cortés A, Casadó V, Lluís C, Ferré S, Ortiz J, et al. Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: σ1-D1-H3 receptor complexes as key targets for reducing cocaine's effects. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 3545-58. PMID 24599455 DOI: 10.1523/JNEUROSCI.4147-13.2014 |
0.505 |
|
| 2013 |
Navarro G, Moreno E, Bonaventura J, Brugarolas M, Farré D, Aguinaga D, Mallol J, Cortés A, Casadó V, Lluís C, Ferre S, Franco R, Canela E, McCormick PJ. Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers. Plos One. 8: e61245. PMID 23637801 DOI: 10.1371/Journal.Pone.0061245 |
0.589 |
|
| 2013 |
Navarro G, McCormick PJ, Mallol J, Lluís C, Franco R, Cortés A, Casadó V, Canela EI, Ferré S. Detection of receptor heteromers involving dopamine receptors by the sequential BRET-FRET technology. Methods in Molecular Biology (Clifton, N.J.). 964: 95-105. PMID 23296780 DOI: 10.1007/978-1-62703-251-3_7 |
0.627 |
|
| 2012 |
González S, Moreno-Delgado D, Moreno E, Pérez-Capote K, Franco R, Mallol J, Cortés A, Casadó V, Lluís C, Ortiz J, Ferré S, Canela E, McCormick PJ. Circadian-related heteromerization of adrenergic and dopamine D₄ receptors modulates melatonin synthesis and release in the pineal gland. Plos Biology. 10: e1001347. PMID 22723743 DOI: 10.1371/Journal.Pbio.1001347 |
0.555 |
|
| 2012 |
Moeller FG, Steinberg JL, Lane SD, Kjome KL, Ma L, Ferre S, Schmitz JM, Green CE, Bandak SI, Renshaw PF, Kramer LA, Narayana PA. Increased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A(2A) Antagonist in Cocaine Dependent Subjects. Frontiers in Psychiatry. 3: 44. PMID 22654774 DOI: 10.3389/Fpsyt.2012.00044 |
0.393 |
|
| 2011 |
Orrú M, Zanoveli JM, Quiroz C, Nguyen HP, Guitart X, Ferré S. Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease. Experimental Neurology. 232: 76-80. PMID 21867705 DOI: 10.1016/j.expneurol.2011.08.005 |
0.316 |
|
| 2011 |
Armentero MT, Pinna A, Ferré S, Lanciego JL, Müller CE, Franco R. Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease Pharmacology & Therapeutics. 132: 280-299. PMID 21810444 DOI: 10.1016/J.Pharmthera.2011.07.004 |
0.635 |
|
| 2011 |
Orrú M, Quiroz C, Guitart X, Ferré S. Pharmacological evidence for different populations of postsynaptic adenosine A2A receptors in the rat striatum. Neuropharmacology. 61: 967-74. PMID 21752341 DOI: 10.1016/j.neuropharm.2011.06.025 |
0.32 |
|
| 2011 |
Ferré S, Quiroz C, Orru M, Guitart X, Navarro G, Cortés A, Casadó V, Canela EI, Lluis C, Franco R. Adenosine A(2A) Receptors and A(2A) Receptor Heteromers as Key Players in Striatal Function. Frontiers in Neuroanatomy. 5: 36. PMID 21731559 DOI: 10.3389/fnana.2011.00036 |
0.379 |
|
| 2011 |
Orru M, Bakešová J, Brugarolas M, Quiroz C, Beaumont V, Goldberg SR, Lluís C, Cortés A, Franco R, Casadó V, Canela EI, Ferré S. Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists. Plos One. 6: e16088. PMID 21264319 DOI: 10.1371/journal.pone.0016088 |
0.319 |
|
| 2011 |
Justinová Z, Ferré S, Redhi GH, Mascia P, Stroik J, Quarta D, Yasar S, Müller CE, Franco R, Goldberg SR. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist. Addiction Biology. 16: 405-15. PMID 21054689 DOI: 10.1111/J.1369-1600.2010.00258.X |
0.436 |
|
| 2011 |
Ferré S, Lluis C, Lanciego JL, Franco R. Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D₁-D₃ receptor heteromer. Cns & Neurological Disorders Drug Targets. 9: 596-600. PMID 20632968 DOI: 10.2174/187152710793361603 |
0.54 |
|
| 2010 |
Ferré S, Navarro G, Casadó V, Cortés A, Mallol J, Canela EI, Lluís C, Franco R. G protein-coupled receptor heteromers as new targets for drug development. Progress in Molecular Biology and Translational Science. 91: 41-52. PMID 20691958 DOI: 10.1016/S1877-1173(10)91002-8 |
0.443 |
|
| 2010 |
Ferré S, Lluís C, Justinova Z, Quiroz C, Orru M, Navarro G, Canela EI, Franco R, Goldberg SR. Adenosine-cannabinoid receptor interactions. Implications for striatal function. British Journal of Pharmacology. 160: 443-53. PMID 20590556 DOI: 10.1111/j.1476-5381.2010.00723.x |
0.515 |
|
| 2010 |
Quiroz C, Pearson V, Gulyani S, Allen R, Earley C, Ferré S. Up-regulation of striatal adenosine A(2A) receptors with iron deficiency in rats: effects on locomotion and cortico-striatal neurotransmission. Experimental Neurology. 224: 292-8. PMID 20385128 DOI: 10.1016/j.expneurol.2010.04.004 |
0.442 |
|
| 2010 |
Ferré S. Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine. Journal of Alzheimer's Disease : Jad. S35-49. PMID 20182056 DOI: 10.3233/JAD-2010-1400 |
0.526 |
|
| 2009 |
Ferré S, Franco R. Oligomerization of G-protein-coupled receptors: a reality. Current Opinion in Pharmacology. 10: 1-5. PMID 20015687 DOI: 10.1016/j.coph.2009.11.002 |
0.372 |
|
| 2009 |
Quiroz C, Luján R, Uchigashima M, Simoes AP, Lerner TN, Borycz J, Kachroo A, Canas PM, Orru M, Schwarzschild MA, Rosin DL, Kreitzer AC, Cunha RA, Watanabe M, Ferré S. Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway. Thescientificworldjournal. 9: 1321-44. PMID 19936569 DOI: 10.1100/Tsw.2009.143 |
0.699 |
|
| 2009 |
Casadó V, Cortés A, Mallol J, Pérez-Capote K, Ferré S, Lluis C, Franco R, Canela EI. GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers? Pharmacology & Therapeutics. 124: 248-57. PMID 19664655 DOI: 10.1016/j.pharmthera.2009.07.005 |
0.347 |
|
| 2009 |
Ferrada C, Moreno E, Casadó V, Bongers G, Cortés A, Mallol J, Canela EI, Leurs R, Ferré S, Lluís C, Franco R. Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. British Journal of Pharmacology. 157: 64-75. PMID 19413572 DOI: 10.1111/J.1476-5381.2009.00152.X |
0.62 |
|
| 2009 |
Cabello N, Gandía J, Bertarelli DC, Watanabe M, Lluís C, Franco R, Ferré S, Luján R, Ciruela F. Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells. Journal of Neurochemistry. 109: 1497-507. PMID 19344374 DOI: 10.1111/J.1471-4159.2009.06078.X |
0.623 |
|
| 2009 |
Ferré S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, Lohse MJ, Mackie K, Milligan G, Pfleger KD, Pin JP, Volkow ND, et al. Building a new conceptual framework for receptor heteromers. Nature Chemical Biology. 5: 131-4. PMID 19219011 DOI: 10.1038/Nchembio0309-131 |
0.478 |
|
| 2009 |
Ferré S, Goldberg SR, Lluis C, Franco R. Looking for the role of cannabinoid receptor heteromers in striatal function. Neuropharmacology. 56: 226-34. PMID 18691604 DOI: 10.1016/j.neuropharm.2008.06.076 |
0.529 |
|
| 2008 |
Franco R, Casadó V, Cortés A, Pérez-Capote K, Mallol J, Canela E, Ferré S, Lluis C. Novel pharmacological targets based on receptor heteromers. Brain Research Reviews. 58: 475-82. PMID 18620000 DOI: 10.1016/j.brainresrev.2008.06.002 |
0.529 |
|
| 2008 |
Ferrada C, Ferré S, Casadó V, Cortés A, Justinova Z, Barnes C, Canela EI, Goldberg SR, Leurs R, Lluis C, Franco R. Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology. 55: 190-7. PMID 18547596 DOI: 10.1016/J.Neuropharm.2008.05.008 |
0.621 |
|
| 2008 |
Müller CE, Ferré S. Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders. Recent Patents On Cns Drug Discovery. 2: 1-21. PMID 18221214 DOI: 10.2174/157488907779561772 |
0.455 |
|
| 2008 |
Ferre S, Ciruela F, Borycz J, Solinas M, Quarta D, Antoniou K, Quiroz C, Justinova Z, Lluis C, Franco R, Goldberg SR. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Frontiers in Bioscience : a Journal and Virtual Library. 13: 2391-9. PMID 17981720 DOI: 10.2741/2852 |
0.56 |
|
| 2007 |
Ferré S. An update on the mechanisms of the psychostimulant effects of caffeine. Journal of Neurochemistry. 105: 1067-79. PMID 18088379 DOI: 10.1111/j.1471-4159.2007.05196.x |
0.517 |
|
| 2007 |
Franco R, Casadó V, Cortés A, Ferrada C, Mallol J, Woods A, Lluis C, Canela EI, Ferré S. Basic concepts in G-protein-coupled receptor homo- and heterodimerization. Thescientificworldjournal. 7: 48-57. PMID 17982576 DOI: 10.1100/Tsw.2007.197 |
0.505 |
|
| 2007 |
Ferré S. Heteromerization of G-protein-coupled receptors. Implications for central nervous system function and dysfunction. Thescientificworldjournal. 7: 46-7. PMID 17982575 DOI: 10.1100/tsw.2007.215 |
0.384 |
|
| 2007 |
Casadó V, Cortés A, Ciruela F, Mallol J, Ferré S, Lluis C, Canela EI, Franco R. Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index. Pharmacology & Therapeutics. 116: 343-54. PMID 17935788 DOI: 10.1016/J.Pharmthera.2007.05.010 |
0.498 |
|
| 2006 |
Karcz-Kubicha M, Ferré S, Díaz-Ruiz O, Quiroz-Molina C, Goldberg SR, Hope BT, Morales M. Stimulation of adenosine receptors selectively activates gene expression in striatal enkephalinergic neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2173-9. PMID 16452987 DOI: 10.1038/Sj.Npp.1301035 |
0.596 |
|
| 2005 |
Antoniou K, Papadopoulou-Daifoti Z, Hyphantis T, Papathanasiou G, Bekris E, Marselos M, Panlilio L, Müller CE, Goldberg SR, Ferré S. A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors. Psychopharmacology. 183: 154-162. PMID 16205915 DOI: 10.1007/S00213-005-0173-6 |
0.365 |
|
| 2005 |
Agnati LF, Ferre S, Burioni R, Woods A, Genedani S, Franco R, Fuxe K. Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases. Neuromolecular Medicine. 7: 61-78. PMID 16052039 DOI: 10.1385/Nmm:7:1-2:061 |
0.626 |
|
| 2005 |
Rassoulpour A, Wu HQ, Ferre S, Schwarcz R. Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum. Journal of Neurochemistry. 93: 762-5. PMID 15836634 DOI: 10.1111/j.1471-4159.2005.03134.x |
0.391 |
|
| 2005 |
Solinas M, Ferré S, Antoniou K, Quarta D, Justinova Z, Hockemeyer J, Pappas LA, Segal PN, Wertheim C, Müller CE, Goldberg SR. Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats. Psychopharmacology. 179: 576-86. PMID 15696333 DOI: 10.1007/S00213-004-2081-6 |
0.527 |
|
| 2005 |
Schindler CW, Karcz-Kubicha M, Thorndike EB, Müller CE, Tella SR, Ferré S, Goldberg SR. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists British Journal of Pharmacology. 144: 642-650. PMID 15678095 DOI: 10.1038/Sj.Bjp.0706043 |
0.426 |
|
| 2004 |
Schindler CW, Karcz-Kubicha M, Thorndike EB, Müller CE, Tella SR, Goldberg SR, Ferré S. Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680. European Journal of Pharmacology. 484: 269-275. PMID 14744613 DOI: 10.1016/J.Ejphar.2003.11.010 |
0.608 |
|
| 2003 |
Justinova Z, Ferre S, Segal PN, Antoniou K, Solinas M, Pappas LA, Highkin JL, Hockemeyer J, Munzar P, Goldberg SR. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats. The Journal of Pharmacology and Experimental Therapeutics. 307: 977-86. PMID 14557381 DOI: 10.1124/Jpet.103.056762 |
0.402 |
|
| 2002 |
Munzar P, Justinova Z, Kutkat SW, Ferré S, Goldberg SR. Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology. 161: 348-55. PMID 12073161 DOI: 10.1007/s00213-002-1075-5 |
0.593 |
|
| 2002 |
Giménez-Llort L, Wang FH, Ogren SO, Ferré S. Local dopaminergic modulation of the motor activity induced by N-methyl-D-aspartate receptor stimulation in the ventral hippocampus. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 737-43. PMID 12007744 DOI: 10.1016/S0893-133X(01)00411-0 |
0.525 |
|
| 2002 |
Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J, Canela EI, Zoli M, Agnati LF, Ibanez CF, Lluis C, ... ... Ferre S, et al. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. The Journal of Biological Chemistry. 277: 18091-7. PMID 11872740 DOI: 10.1074/jbc.M107731200 |
0.671 |
|
| Show low-probability matches. |